[The physicochemical anticomplement properties of alpha 2-macroglobulin for intravenous administration]

Likars'Ka Sprava
|February 1, 1993
PubMed

Insights

Stabilized alpha-2-macroglobulin maintains its properties and anticomplement activity for one year when stored at 6°C. This indicates the concentrate is safe and ready for intravenous administration.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Alpha-2-macroglobulin is a crucial proteinase inhibitor with therapeutic potential.
  • Maintaining the stability and biological activity of alpha-2-macroglobulin concentrates is essential for clinical applications.

Purpose of the Study:

  • To evaluate the long-term stability and biological properties of a stabilized alpha-2-macroglobulin composition.
  • To determine the safety and suitability of the stabilized concentrate for intravenous administration.

Main Methods:

  • Storage of stabilized alpha-2-macroglobulin composition at (6 +/- 2) degrees C for one year.
  • Assessment of physico-chemical properties.
  • Evaluation of biological properties, specifically anticomplement activity.

Main Results:

  • The stabilized alpha-2-macroglobulin composition retained its physico-chemical properties throughout the one-year storage period.
  • Anticomplement activity remained unchanged during storage, indicating preserved biological function.
  • The concentrate demonstrated safety for the body, confirmed by unchanged anticomplement activity.

Conclusions:

  • Stabilized alpha-2-macroglobulin exhibits excellent stability for at least one year under refrigerated conditions.
  • The stabilized concentrate maintains its therapeutic potential and is safe for intravenous administration.
  • This finding supports the clinical readiness of the stabilized alpha-2-macroglobulin for therapeutic use.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...